Clinical Trial: Development and External Validation of a Prognostic Model for DFS After Curative Resection of Duodenal GIST

U.S., Sept. 24 -- ClinicalTrials.gov registry received information related to the study (NCT07837271) titled 'Development and External Validation of a Prognostic Model for DFS After Curative Resection of Duodenal GIST' on Sept. 12.

Brief Summary: Gastrointestinal stromal tumour (GIST) is the most common mesenchymal neoplasm of the digestive tract, originating from the interstitial cells of Cajal. GIST can arise anywhere along the gastrointestinal tract, but most commonly occurs in the stomach (50%-60%) and small intestine (20%-30%), with the colorectal region accounting for approximately 10%. Duodenal GIST is a relatively rare subtype, comprising approximately 5% of all GISTs. Due to its low incidence, clinical understanding of duodenal GI...